Association of endothelia nitric oxide synthase gene rs1799983 polymorphism with susceptibility to prostate cancer: a meta-analysis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Goh CL, Schumacher FR, Easton D, Muir K, Henderson B, Kote-Jarai Z, et al. Genetic variants associated with predisposition to prostate cancer and potential clinical implications. J Intern Med. 2012;271:353–65.
Varghese JS, Easton DF. Genome-wide association studies in common cancers–what have we learnt? Curr Opin Genet Dev. 2010;20:201–9.
Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18:11–22.
Amankwah EK, Sellers TA, Park JY. Gene variants in the angiogenesis pathway and prostate cancer. Carcinogenesis. 2012;33:1259–69.
Jain L, Vargo CA, Danesi R, Sissung TM, Price DK, Venzon D, et al. The role of vascular endothelial growth factor snps as predictive and prognostic markers for major solid tumors. Mol Cancer Ther. 2009;8:2496–508.
Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, et al. Evidence of association of the ecnos gene polymorphism with plasma no metabolite levels in humans. Biochem Biophys Res Commun. 1998;245:190–3.
Tong X, Li H. Enos protects prostate cancer cells from TRAIL-induced apoptosis. Cancer Lett. 2004;210:63–71.
Babaei S, Teichert-Kuliszewska K, Zhang Q, Jones N, Dumont DJ, Stewart DJ. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol. 2003;162:1927–36.
Nihei N, Ohta S, Kuramochi H, Kugoh H, Oshimura M, Barrett JC, et al. Metastasis suppressor gene(s) for rat prostate cancer on the long arm of human chromosome 7. Genes Chromosom Cancer. 1999;24:1–8.
Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, et al. Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur J Cancer Prev. 2002;11:343–50.
Brankovic A, Brajuskovic G, Nikolic Z, Vukotic V, Cerovic S, Savic-Pavicevic D, et al. Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population. Int J Exp Pathol. 2013;94(6):355–61.
Lee KM, Kang D, Park SK, Berndt SI, Reding D, Chatterjee N, et al. Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis. 2009;30:621–5.
Lebrec JJ, Stijnen T, van Houwelingen HC: Dealing with heterogeneity between cohorts in genomewide snp association studies. Statistical applications in genetics and molecular biology 2010; 9: Article 8.
Ziaei SA, Samzadeh M, Jamaldini SH, Afshari M, Haghdoost AA, Hasanzad M. Endothelial nitric oxide synthase glu298asp polymorphism as a risk factor for prostate cancer. Int J Biol Markers. 2012;28:43–8.
Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Effects of the t-786c, g894t, and intron 4 vntr (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer. Urol Oncol. 2012;31:1132–40.
Marangoni K, Neves AF, Cardoso AM, Santos WK, Faria PC, Goulart LR. The endothelial nitric oxide synthase glu-298-asp polymorphism and its mrna expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia. Cancer Detect Prev. 2006;30:7–13.
Pabalan NA. Meta-analysis in cancer genetics. Asian Pac J Cancer Prev. 2010;11:33–8.
Lin DY, Sullivan PF. Meta-analysis of genome-wide association studies with overlapping subjects. Am J Hum Genet. 2009;85:862–72.
Hao Y, Montiel R, Huang Y. Endothelial nitric oxide synthase (enos) 894 g > t polymorphism is associated with breast cancer risk: a meta-analysis. Breast Cancer Res Treat. 2010;124:809–13.
Arikan S, Cacina C, Guler E, Culcu S, Tuna G, Yaylim-Eraltan I. The effects of nos3 glu298asp variant on colorectal cancer risk and progression in Turkish population. Mol Biol Rep. 2012;39:3245–9.
Verim L, Toptas B, Ozkan NE, Cacina C, Turan S, Korkmaz G, et al. Possible relation between the nos3 gene glu298asp polymorphism and bladder cancer in Turkey. Asian Pac J Cancer Prev. 2013;14:665–8.
Royo JL, Moreno-Nogueira JA, Galan JJ, Gonzalez-Martin A, Ruiz A, Gonzalez-Mancha R, et al. Lack of association between nos3 glu298asp and breast cancer risk: a case-control study. Breast Cancer Res Treat. 2006;100:331–3.
Kim YJ, Lee SJ, Kim JG, Sohn SK, Chae YS, Moon JH, et al. No association of the enos gene polymorphisms with survival in patients with colorectal cancer. Med Oncol. 2011;28:1075–9.
Zhang Y, Jia Q, He Q, Shen J, Yang J, Xue P, Ma M, Xu R, Du L: The glu298asp polymorphism in the nos3 gene and the risk of prostate cancer. Tumour biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 2014.